Skip to content
10-K

Annual Report

CHAMPIONS ONCOLOGY, INC. CSBR

0001628280-24-032321

← back to feed
Filed
Jul 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jul 18, 2024 13.59M sh
Shares Diluted FY 2024 · Apr 30, 2023 13.54M sh
Stock Repurchased FY 2024 · Apr 30, 2023 $74K
Capex FY 2024 · Apr 30, 2023 $2.87M
Operating Cash Flow FY 2024 · Apr 30, 2023 $3.97M
Current Liabilities FY 2024 · Apr 30, 2023 $21.73M
Total Liabilities FY 2024 · Apr 30, 2023 $29.68M
Current Assets FY 2024 · Apr 30, 2023 $19.46M
Total Assets FY 2024 · Apr 30, 2023 $34.31M
Eps Diluted FY 2024 · Apr 30, 2023 −$0.39
Eps Basic FY 2024 · Apr 30, 2023 −$0.39
Sga Expense FY 2024 · Apr 30, 2023 $10.24M
Rd Expense FY 2024 · Apr 30, 2023 $11.55M
Net Income FY 2024 · Apr 30, 2023 −$5.34M
Operating Income FY 2024 · Apr 30, 2023 −$5.26M
Cost Of Revenue FY 2024 · Apr 30, 2023 $29.53M
Revenue FY 2024 · Apr 30, 2023 $53.87M
Stockholders Equity FY 2024 · Apr 30, 2022 $9.1M